LG Chem initiates phase 2 clinical trials in patients with defects in MC4R pathway causing obesity and hyperphagia
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
LG Chem will receive totaling up to $95.5 million for the China rights
Subscribe To Our Newsletter & Stay Updated